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Conclusion: With this method calculations inaccuracies 
caused by the high density materials are avoided. We 
recommend the discussion of the use of the technique 
proposed with the physician for each treatment of head and 
neck patient with dental prostheses.  
The techniques in this study are being developed currently 
for VMAT technique. 
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Purpose or Objective: To evaluate and compare the plan 
quality and efficacy of flattened and flattening-filter-free 
(FFF) photon beams in external beam RT for high-risk 
prostate cancer patients in the context of hypo-fractionated 
Stereotactic Ablative Radiotherapy (SABR) to the prostate 
and pelvic lymph nodes (LN). 
 
Material and Methods: 10 prostate cancer (PCa) patients who 
previously received RT to the prostate and pelvic nodes, 
were planned in Varian Eclipse using two full arcs with 6MV 
flattened, 6MV and 10MV FFF photon beams. The prescribed 
dose was 40Gy in 5 fractions for the planning target volume 
to prostate PTV(psv) (prostate and seminal vesicles) and 25Gy 
in 5 fractions for the PTV(LN). All plans were optimized using 
the same objectives and constraints. Plans were then 
evaluated for PTV coverage, dose fall-off, OAR doses for the 
rectum, bladder, small bowel, prostatic urethra, 
neurovascular bundle, femoral heads, penile bulb and the 
sigmoid colon. Physical dose metrics, EUDs, tumour control 
probability (TCP) and normal tissue complication probability 
(NTCPs) using the LKB model were investigated. The number 
of monitor units and the treatment delivery times were also 
compared. Statistical differences were evaluated using a 
paired sample Wilcoxon signed rank test with a significance 
level of 0.05% 
 
Results: All evaluated plans were highly conformal CI =1.2 
and CN ≥0.94. There was no significant difference in the PTV 
dose coverage using all energies compared.Significant 
increase in high dose (R50) and low dose (R25) spillage 
outside the PTV in 6MV flattened beams compared to FFF 
plans was observed. Superior plans were obtained using 10 
MV FFF beams in terms of mean and minimum rectal dose, 
high and low dose spill outside the PTV and treatment time 
were also minimal. Despite the significantly lower monitor 
units (MU) in 6MV plans, these plans delivery times were the 
largest among the three compared techniques due to dose 
rate limitations (maximum dose rate 600MU/min). 
Furthermore, the high dose spillage was found to be higher 
for 6MV. When comparing 6MV FFF and 10MV FFF plans, only 




Conclusion: Using two full arcs, highly conformal SABR VMAT 
plans for prostate and pelvic lymph node were achieved with 
6MV FFF and 10MV FFF photon beams. A minor increase in the 
number of MU in 6MV FFF plans was observed; however, the 
increase in the treatment time was found to be negligible. 
Significant reduction in the high dose spillage was obtained 
with 10MVFFF beams suggesting that although both energies 
are suitable for use in prostate and lymph node SABR 10MV 
FFF is superior. 
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Purpose or Objective: This study evaluates a single isocentre 
technique for SRS for patients with multiple cranial 
metastases and compares to the local approach of a single 
isocentre per metastasis. 
 
Material and Methods: At our centre, SRS treatment for 
multiple cranial metastases is planned in iPlan (Brainlab, 
Germany) using a single isocentre per metastasis, with an 
arrangement of nine static non-coplanar fields (SCF). An 
alternative VMAT-based approach, described by Clark et al 
(2012), uses RapidArcTM to give highly conformal dose 
distributions with a single isocentre. Eight patients each with 
three metastases, previously treated using our SCF 
technique, were re-planned using the single isocentre 
RapidArc approach. Plans were compared using PTV ICRU 
dose conformity (CI), Paddick gradient index (GI), ICRU 
homogeneity (HI) and whole brain doses. Plans were 
prescribed to the 80% isodose, with 100 % coverage of the 
target volume. The Wilcoxon’s signed rank test was used to 
compare CI, HI and GI between the two techniques. 
 
Results: There was a statistically significant improvement in 
the CI for RapidArc (p=0.003), suggesting superior conformity 
to the tumour. On average, iPlan plans were more 
homogeneous (p=0.03). In general RapidArc gives a higher 
maximum dose to PTVs (p=0.002). iPlan has a superior GI 
around each PTV (p<0.001); RapidArc has three unexpectedly 
high GI per metastasis values from three different patients 
with single tumour volumes less than 0.1cm2. GI per plan is 
greater for RapidArc than iPlan. However this is misleading as 
iPlan treats a greater volume to 2, 5 and 12.5 Gy by 1.3%, 
